Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients. (2021)

First Author: Harden PN

Attributed to: The TWO Study: A Phase II trial of regulatory T cells in renal transplantation - can we achieve sirolimus monotherapy? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/ajt.16395

PubMed Identifier: 33171020

Publication URI: http://europepmc.org/abstract/MED/33171020

Type: Journal Article/Review

Volume: 21

Parent Publication: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Issue: 4

ISSN: 1600-6135